Clinical Trial Update: Intravesical BCG vs GEMDOCE in NMIBC [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating intravesical Bacillus Calmette-Guérin (BCG) versus GEMDOCE for non-muscle-invasive bladder cancer is currently active but not recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• Bacillus Calmette-Guérin (BCG) (Bacillus Calmette-Guérin)
• GEMDOCE (Gemcitabine and Docetaxel intravesical formulation)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Non-muscle-invasive Bladder Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING